Compare MGTX & THRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MGTX | THRM |
|---|---|---|
| Founded | 2015 | 1991 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.4B |
| IPO Year | 2018 | 1996 |
| Metric | MGTX | THRM |
|---|---|---|
| Price | $10.96 | $35.06 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 5 |
| Target Price | $24.57 | ★ $37.20 |
| AVG Volume (30 Days) | ★ 824.2K | 268.9K |
| Earning Date | 05-12-2026 | 04-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 33.02 | N/A |
| EPS | ★ 1.30 | 0.28 |
| Revenue | $81,391,000.00 | ★ $554,979,000.00 |
| Revenue This Year | $141.38 | $4.96 |
| Revenue Next Year | N/A | $7.12 |
| P/E Ratio | ★ $8.50 | $121.04 |
| Revenue Growth | ★ 144.57 | 50.16 |
| 52 Week Low | $6.62 | $27.00 |
| 52 Week High | $15.35 | $48.35 |
| Indicator | MGTX | THRM |
|---|---|---|
| Relative Strength Index (RSI) | 26.47 | 36.11 |
| Support Level | $8.84 | $34.15 |
| Resistance Level | $11.85 | $39.14 |
| Average True Range (ATR) | 0.56 | 1.37 |
| MACD | -0.28 | -0.39 |
| Stochastic Oscillator | 9.42 | 26.97 |
MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company focused on developing targeted therapies for diseases with high unmet need, including radiation-induced xerostomia, Parkinson's disease, and AIPL1-associated retinal dystrophy. The company's pipeline is supported by end-to-end in-house manufacturing capabilities, including GMP viral vector production, plasmid manufacturing, and quality control, enabling development from IND to commercial supply. It also utilizes proprietary platforms in viral vector optimization and riboswitch-based gene regulation to enhance efficacy and reduce dosage. The company operates in the United States, the United Kingdom, and the European Union.
Gentherm Inc is an automotive parts manufacturer. The business activities of the group function through the Automotive and Medical segments. The vast majority of the firm's revenue comes from the Automotive segment, which includes automotive climate comfort systems, automotive cable systems, battery performance solutions, and automotive electronics and software systems. The medical segment is comprised of the results from the patient temperature management business in the medical industry. Its geographical segments are the USA, China, South Korea, Germany, Japan, the Czech Republic, and other countries.